Porth's Essentials of Pathophysiology, 4e

157

Neoplasia

C h a p t e r 7

50. Miser WF. Cancer screening in the primary care setting. Prim Care 2007;34:137–167. 51. Smith RA, Brooks D, Cokkinides V, et al. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening and lung cancer screening. CA Cancer J Clin. 2013;63(2):88–105. 52. Rosenberg SA. Cancer management: surgical oncology: general issues. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology . 9th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2011:268–276. 53. Jeremic B. Radiation therapy. Hematol Oncol Clin North Am 2004;18:1–12. 54. Morgan MA, Ten Haken RK, Lawrence TS. Radiation oncology. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology . 9th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2011:289–311. 55. Willers H, Held KD. Introduction to clinical radiation biology. Hematol Oncol Clin North Am . 2006;20:1–24. 56. Hogle WP. The state of the art in radiation therapy. Semin Oncol Nurs. 2006;22(4):212–220. 57. Ikushima H. Radiation therapy: state of the art and the future. J Med Invest 2010;97:1–11. 58. Chu E, Sartorelli AC. Cancer chemotherapy. In: Katzung BG, eds. Basic and Clinical Pharmacology . 10th ed. New York, NY. McGraw-Hill; 2012:949–975. 59. DeVita VT Jr, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology . 9th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:360–498. 60. Neuss MN, Polocich M, McNiff K, et al. 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for safe administration and management of oral chemotherapy. Oncol Nurs Forum. 2013;40(3):325–233. 61. Hawkins R. Hormone therapy in cancer. Oncol Nurs Updates. 2002;9(3):1–16. 62. Altundag K, Ibrahim NK. Aromatase inhibitors in breast cancer: an overview. Oncologist . 2006;11:553–562. 63. Kuroki M, Miyamoto S, Morisaki T, et al. Biological response modifiers in cancer biotherapy. Anticancer Res . 2012;32: 2229–2233. 64. Kirkwood JM, Butterfield LH, Tarhini A, et al. Immunotherapy in cancer 2012. CA Cancer J Clin. 2012;62(5):309–335. 65. Robinson MK, Borghael H, Adams GP, et al. Monoclonal antibodies. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology . 9th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:499–507. 66. Sharkey RM, Goldenberg DM. Targeted therapy of cancer: new prospects for antibodies and immunoconjugates. CA Cancer J Clin . 2006;56:226–243.

67. Goetsch CM. Genetic tumor profiling and genetically targeted cancer therapy. Semin Oncol Nurs. 2011;27(3):34–44. 68. Asselin BL. Epidemiology of childhood and adolescent cancer. In: Kliegman RM, Stanton BF, St. Geme JW, et al., eds. Nelson Textbook of Pediatrics . 19th ed. Philadelphia, PA: W.B. Saunders; 2011:1725–1727. 69. Smith LL. Molecular and cellular biology of cancer. In: Kliegman RM, Stanton BF, St. Geme JW, et al., eds. Nelson Textbook of Pediatrics . 19th ed. Philadelphia, PA: W.B. Saunders; 2011:1727–1728. 70. Richey K. Principles of diagnosis. In: Kliegman RM, Stanton BF, St. Geme JW, et al., eds. Nelson Textbook of Pediatrics . 19th ed. Philadelphia, PA: W.B. Saunders; 2011:1729–1731. 71. Fragkandrea J, Nixon JA, Panagopoulou P. Signs and symptoms of childhood cancer: a guide to early recognition. Am Fam Physician. 2013;88(3):185–192. 72. Bleyer A, Rtchey AK. Principles of treatment. In: Kliegman RM, Stanton BF, St. Geme JW, et al., eds. Nelson Textbook of Pediatrics . 19th ed. Philadelphia, PA: W.B. Saunders; 2011:1732–1741. 73. Armstrong GT, Stoval M, Robison LL. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivors study. Radiat Res . 2010;17:840–850. 74. Schmidt D, Anderson LA, Bingen K. Late effects in adult survivors of childhood cancer: Considerations for the general practitioner. Wis Med J. 2010;100(2):98–107. 75. Henderson TTO. Childhood cancer survivors: transition in adult-focused risk-based care. Pediatrics . 2010;126:127–136. 76. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med . 2006;355:1572–1582. 77. Cohen LE. Endocrine late effects of cancer treatment. Endocrinol Metab Clin North Am . 2005;34:769–789.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter: •  NCLEX-Style Questions and Other Resources

on

, http://thePoint.lww.com/PorthEssentials4e

• Study Guide for Essentials of Pathophysiology • Concepts in Action Animations • Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu